一种自组装的,经过基因工程改造的,辐射瘤细胞残渣疫苗
Yajie Sun1,2, Yan Hu1,2, Yuanyuan Geng3
1Cancer Center Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China.
Exploration (Beijing, China)
|October 23, 2024
概括
这项研究介绍了HA@RTD,一种新的癌症疫苗,结合了辐射瘤细胞残渣 (RTD) 和酸 (HA). 这种创新的疫苗有效地激活抗瘤免疫力,并预防单剂量小鼠的瘤生长.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 生物材料是一种生物材料.
背景情况:
- 癌症疫苗面临着诸如免疫性差和瘤免疫逃避等挑战.
- 放射治疗可以诱导局部疫苗效应,呈现瘤抗原以激活抗原呈现细胞 (APC).
研究的目的:
- 开发一种新型疫苗系统,HA@RTD,通过将基因工程辐射瘤细胞残骸 (RTD) 与氨酸 (HA) 结合起来.
- 在临床前癌症模型中评估HA@RTD疫苗的免疫性和治疗疗效.
主要方法:
- 癌细胞系的发展过度表达颗粒细胞-巨细胞殖民地刺激因子 (GM-CSF).
- 在HA与RTD蛋白质的共价结合下,形成水凝疫苗 (HA@RTD).
- 使用T细胞受体测序评估免疫反应,并评估小鼠的抗瘤作用.
主要成果:
- 该HA@RTD疫苗证明了抗瘤免疫力的强烈激活.
- 一次HA@RTD免疫接种在小鼠中阻止了瘤生长.
- 该疫苗在治疗已建立瘤的治疗环境中以及与免疫检查点阻塞相结合时显示出有效性.
结论:
- HA@RTD代表了癌症免疫治疗的有前途的新疫苗策略.
- RTD和HA的结合增强了疫苗的免疫性和治疗潜力.
- 这种方法提供了一个潜在的解决方案,以克服当前癌症疫苗开发中的挑战.
相关概念视频
Cancer Vaccines
342
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
342
Tumor Immunotherapy
486
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
486
Vaccinations
44.1K
Overview
44.1K


